(Q34137788)

31 July 2017

1 reference

title

Pharmacogenomics of neurodegenerative diseases (English)

1 reference

31 July 2017

1 reference

1 reference

Maimone D

1

1 reference

31 July 2017

Dominici R

series ordinal

2

1 reference

31 July 2017

Grimaldi LM

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

European Journal of Pharmacology

31 July 2017

1 reference

31 July 2017

413

1 reference

31 July 2017

11-29

1 reference

31 July 2017

1

1 reference

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Glutamate and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Amyotrophic lateral sclerosis. Insights from genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Failure of immunosuppression with a ten- to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Rapid Ca2+ entry through Ca2+-permeable AMPA/Kainate channels triggers marked intracellular Ca2+ rises and consequent oxygen radical production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Synucleins in synaptic plasticity and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Distribution of AMPA-selective glutamate receptor subunits in the human hippocampus and cerebellum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

From entropy to Duino

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Familial aggregation of Parkinson's disease: A population-based case-control study in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Prospects for pharmacological intervention in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

An excitatory amino-acid transporter with properties of a ligand-gated chloride channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A clinical genetic study of Parkinson's disease: evidence for dominant transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

Excitotoxicity in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The ubiquitin pathway in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The topography of cell loss from locus caeruleus in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Parkinson's disease, pesticides, and glutathione transferase polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Histochemical detection of apoptosis in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Amyotrophic lateral sclerosis: serum factors enhance spontaneous and evoked transmitter release at the neuromuscular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Increased risk of Parkinson's disease in parents and siblings of patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

APOE genotyping and response to drug treatment in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

P450 enzymes and Parkinson's disease: the story so far.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Neuroprotection by the inhibition of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

CYP2D6 polymorphism and Parkinson's disease susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Nerve growth factor and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Risk of Alzheimer's disease and duration of NSAID use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Molecular genetics of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Origin and functional consequences of the complex I defect in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Variability and validity of polymorphism association studies in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Peroxynitrite inhibits glutamate transporter subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Caspase-2 mediates neuronal cell death induced by beta-amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-beta peptide degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Mechanisms of neuronal degeneration in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

Therapeutic potential of neurotrophic factors for neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

1 reference

7 January 2021

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900939-0

1 reference

7 January 2021

10.1016/S0014-2999(00)00939-0

Identifiers

DOI

1 reference

release_g6xyoy3ybrbqjmadwwu4cs5k2y

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g6xyoy3ybrbqjmadwwu4cs5k2y

24 November 2022

mapped directly with Wikidata item

1 reference